<DOC>
	<DOCNO>NCT00365924</DOCNO>
	<brief_summary>This methodology trial conduct patient osteoporosis measure change bone quality parameter , micro- macroarchitecture , bone biomarkers bone density follow therapy approve drug , Forteo .</brief_summary>
	<brief_title>A Pilot Methodology Study To Evaluate Changes In Bone Quality Parameters Following Therapy With Forteo</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Teriparatide</mesh_term>
	<criteria>Postmenopausal woman osteoporosis Any therapy product affect bone turnover within 12 month Screening . Bisphosphonate treatment &gt; 1 month total duration time past . In addition , patient must bisphosphonatetreatmentfree least 12 month prior Screening .</criteria>
	<gender>Female</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>12 month therapy postmenopausal woman osteoporosis examine change bone quality parameter</keyword>
</DOC>